Dopamine D4 receptor-deficient mice display cortical hyperexcitability

J Neurosci. 2001 Jun 1;21(11):3756-63. doi: 10.1523/JNEUROSCI.21-11-03756.2001.

Abstract

The dopamine D(4) receptor (D(4)R) is predominantly expressed in the frontal cortex (FC), a brain region that receives dense input from midbrain dopamine (DA) neurons and is associated with cognitive and emotional processes. However, the physiological significance of this dopamine receptor subtype has been difficult to explore because of the slow development of D(4)R agonists and antagonists the selectivity and efficacy of which have been rigorously demonstrated in vivo. We have attempted to overcome this limitation by taking a multidimensional approach to the characterization of mice completely deficient in this receptor subtype. Electrophysiological current and voltage-clamp recordings were performed in cortical pyramidal neurons from wild-type and D(4)R-deficient mice. The frequency of spontaneous synaptic activity and the frequency and duration of paroxysmal discharges induced by epileptogenic agents were increased in mutant mice. Enhanced synaptic activity was also observed in brain slices of wild-type mice incubated in the presence of the selective D(4)R antagonist PNU-101387G. Consistent with greater electrophysiological activity, nerve terminal glutamate density associated with asymmetrical synaptic contacts within layer VI of the motor cortex was reduced in mutant neurons. Taken together, these results suggest that the D(4)R can function as an inhibitory modulator of glutamate activity in the FC.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 4-Aminopyridine / pharmacology
  • Animals
  • Bicuculline / pharmacology
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / physiopathology*
  • Convulsants / pharmacology
  • Dopamine / metabolism
  • Dopamine D2 Receptor Antagonists
  • Dose-Response Relationship, Drug
  • Glutamic Acid / metabolism
  • Immunohistochemistry
  • In Vitro Techniques
  • Membrane Potentials / drug effects
  • Mice
  • Mice, Neurologic Mutants
  • Motor Cortex / drug effects
  • Motor Cortex / metabolism
  • Motor Cortex / physiopathology
  • Neural Inhibition / drug effects
  • Neural Inhibition / genetics
  • Patch-Clamp Techniques
  • Piperazines / pharmacology
  • Presynaptic Terminals / metabolism
  • Pyramidal Cells / drug effects
  • Pyramidal Cells / metabolism
  • Receptors, Dopamine D2 / deficiency*
  • Receptors, Dopamine D2 / genetics
  • Receptors, Dopamine D4
  • Seizures / chemically induced
  • Seizures / physiopathology*
  • Sulfonamides / pharmacology

Substances

  • Convulsants
  • Dopamine D2 Receptor Antagonists
  • Drd4 protein, mouse
  • Piperazines
  • Receptors, Dopamine D2
  • Sulfonamides
  • Receptors, Dopamine D4
  • Glutamic Acid
  • 4-Aminopyridine
  • sonepiprazole
  • Dopamine
  • Bicuculline